(Q34269245)

English

Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Vassilios Ladis

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Giorgos Chouliaras

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Vasilios Berdoukas

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Panagiotis Moraitis

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Kirykos Zannikos

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Eleni Berdoussi

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Christos Kattamis

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

30 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

335-344

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Longitudinal study of survival and causes of death in patients with thalassemia major in Greece

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

6 July 2018

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Reversal of heart failure in thalassemia major by combined chelation therapy: a case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Cardiac status in well-treated patients with thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Complications of beta-thalassemia major in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Impact of thalassemia major on patients and their families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970906

28 October 2018

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20561034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20561034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20561034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone

1 reference

https://pubmed.ncbi.nlm.nih.gov/20561034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register

1 reference

https://pubmed.ncbi.nlm.nih.gov/20561034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/20561034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1600-0609.2010.01491.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34269245&oldid=1544468315"